Skip to Content
Søg Menu

Update om behandling af myelomatose med bispecifikke antitoffer

Hør i denne MEDtalk om Agoston Gyula Szabos perspektivering af tre studier, præsenteret ved ASH 2021, omhandlende behandling af myelomatose med bispecifikt antistof.
Agoston Gyula Szabos

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Several Trials Showed Improvements in the Treatment of Multiple Myeloma

/ BestPractice Nordic
EHA24Myelomatose

Using PRO Data to Assess Treatment Readiness in Multiple Myeloma

/ Tine Rosenberg / Thomas Lund / Jannie Kirkegaard
Myelomatose
Fredrik Schjesvold

Choice of Selinexor in the Treatment of Myeloma

/ Fredrik Schjesvold
Myelomatose Play the Video 7:09

The Missing Link of Light Chain Smoldering Multiple Myeloma

/ Sofie Pohl
Myelomatose
Hanne Norseth

Vaccinating Against Mutated RAS in Multiple Myeloma

/ Hanne Norseth
EHA24Myelomatose Play the Video 3:27
Frida Bugge Askeland

Treating MRD Relapse After First-Line Treatment May Prolong PFS and OS in Myeloma Patients

/ Frida Bugge Askeland
EHA24Myelomatose Play the Video 1:59
Elin Forsgren

Ibrutinib, Lenalidomide, and Rituximab in Relapsed Mantle Cell Lymphoma

/ Elin Forsgren
EHA24Myelomatose Play the Video 2:22
Bruno Paiva

Presidential Symposium: Innovative Tools for Disease Monitoring in Multiple Myeloma

/ Bruno Paiva
EHA24Myelomatose Play the Video 2:51
Sigrun Thorsteinsdottir

The Missing Link of Light Chain Smoldering Multiple Myeloma

/ Sigrun Thorsteinsdottir
EHA24Myelomatose Play the Video 4:00
Back to top